12/19
09:17 am
lsb
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance [Yahoo! Finance]
Low
Report
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance [Yahoo! Finance]
12/19
09:05 am
lsb
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance
Medium
Report
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance
12/12
07:57 pm
lsb
LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China
Low
Report
LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China
10/29
08:30 am
lsb
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
10/29
08:30 am
lsb
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
10/25
08:30 am
lsb
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
Low
Report
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
10/25
08:30 am
lsb
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
Low
Report
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
10/8
08:30 am
lsb
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
Medium
Report
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
10/8
08:30 am
lsb
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
Medium
Report
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance